We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Pilot Study to Evaluate a Telepharmacy Intervention to Improve Inhaler Adherence in Veterans With COPD

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01270594
First Posted: January 5, 2011
Last Update Posted: May 28, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
William S. Middleton Memorial Veterans Hospital
American Society of Health-System Pharmacists
Information provided by (Responsible Party):
University of Wisconsin, Madison
  Purpose

Hypothesis: Can a counseling intervention, delivered by a pharmacist, increase inhaler adherence in veterans with COPD who have demonstrated poor inhaler adherence through pharmacy refill records?

Veterans who receive who receive daily maintenance inhalers from the William S Middleton Memorial Veterans Hospital Pharmacy and who have a medication possession ratio less than 80% over the previous six months will be invited to participate in the study. This study will randomize 100 participants to a usual care arm or a pharmacist counseling intervention. Final data collection will be six months after randomization to determine if both self-reported and refill record adherence has changed.


Condition Intervention Phase
Chronic Obstructive Pulmonary Disease Behavioral: COPD Inhaler Counseling Behavioral: Usual Pharmacy Care Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: A Pilot Study to Evaluate a Telepharmacy Intervention to Improve Inhaler Adherence in Veterans With COPD

Further study details as provided by University of Wisconsin, Madison:

Primary Outcome Measures:
  • Adherence to daily inhaled COPD medications [ Time Frame: Previous six months ]
    Adherence will be measured by pharmacy refill records and by participant self-report


Secondary Outcome Measures:
  • COPD exacerbations [ Time Frame: Previous six months ]
    Participants will be asked how many episodes of worsening their COPD has required additional medical care and/or the use of an oral steroid or antibiotic.


Enrollment: 97
Study Start Date: January 2011
Study Completion Date: April 2012
Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: COPD Counseling Intervention
Pharmacist counseling intervention delivered via telephone.
Behavioral: COPD Inhaler Counseling
The counseling will be performed via telephone by a pharmacist at the William S Middleton Memorial Veterans Hospital. The counseling will include education about inhaled COPD medication, inhaler technique review, reminder tools, and motivational interviewing.
Usual Care Behavioral: Usual Pharmacy Care
The usual care arm will receive standard care from the William S Middleton Memorial Veterans Hospital pharmacists.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   60 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Male and female veterans established with the William S. Middleton Memorial Veterans Hospital and associated Community Based Outpatient Clinics
  • Fill their inhaled COPD medications with the VHA
  • A diagnosis of COPD and an active prescription for a twice daily long-acting beta-agonist and/or long-acting anticholinergic with or without a prescription for inhaled corticosteroids for at least 4 months.
  • Non-adherence to at least one COPD medication, a medication possession ratio of less than 80% or over 120% via the pharmacy refill records.

Exclusion Criteria:

  • Patients with a diagnosis or electronic medical record note regarding significant hearing impairment.
  • Patients with a diagnosis regarding cognitive deficit and activated power of attorney.
  • Patients who use daily nebulization instead of inhalers for maintenance medication.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01270594


Locations
United States, Wisconsin
UW-Madison School of Pharmacy
Madison, Wisconsin, United States, 53705
Sponsors and Collaborators
University of Wisconsin, Madison
William S. Middleton Memorial Veterans Hospital
American Society of Health-System Pharmacists
Investigators
Principal Investigator: Arthur Schuna, RPh MS William S. Middleton Memorial Veterans Hospital
  More Information

Responsible Party: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT01270594     History of Changes
Other Study ID Numbers: M-2010-1187
First Submitted: January 3, 2011
First Posted: January 5, 2011
Last Update Posted: May 28, 2015
Last Verified: May 2015

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases


To Top